First Trust Advisors
VIE

First Trust Advisors’s Viela Bio, Inc. Common Stock VIE Stock Holding History

First Trust Advisors’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-64,497
Closed -$2.79M – 2547
2020
Q2 		$2.79M Buy
64,497
+9,326
+17% +$422K ﹤0.01% 1214
2020
Q1 		$2.1M Buy
+55,171
New +$2.15M ﹤0.01% 1248

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

First Trust Advisors's VIE Position: Q3 2020 in Review

First Trust Advisors sold out of Viela Bio, Inc. Common Stock (VIE) in Q3 2020, closing a stake of 64,497 shares — an estimated $2.79M sold.

First Trust Advisors first reported a position in VIE in Q1 2020 and held it in 2 quarters. The position peaked at $2.79M in Q2 2020. 60 funds tracked by Wall St. Rank hold VIE as of Q3 2020.

  • First Trust Advisors reported no remaining Viela Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • First Trust Advisors sold 64,497 Viela Bio, Inc. Common Stock shares in Q3 2020, an estimated $2.79M.
  • First Trust Advisors first reported a position in Viela Bio, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • First Trust Advisors's Viela Bio, Inc. Common Stock position peaked at $2.79M in Q2 2020.
  • 60 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q3 2020.

Based on First Trust Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.